Dr. Molcho has served as an external director on our Board of Directors and on our Audit Committee since 2010. In addition, Dr. Molcho has served on our Compensation Committee since 2012 and as Chairperson of our Compensation Committee since 2022. Dr. Molcho is the Founder and Chairman of Biolojic Design Ltd., a technology platform that encourages human antibody discoveries, and is a venture partner at Forbion Capital Partners, a Dutch life sciences venture capital firm. In 2012, he became the cofounder, CEO, and director of Ayana Pharma Ltd. (formerly DoxoCure), a privately held company engaged in the manufacturing of liposome-based therapeutics. He currently serves on the Board of Directors of Circulite Inc. and NovoGI. From 2006 through 2008, Dr. Molcho served as the Chief Executive Officer and Chairman of Neovasc Medical, a privately held Israeli medical device company. From 2001 through 2006, Dr. Molcho was a managing director and the head of life sciences of Giza Venture Capital and, in that capacity, was involved in the founding of our company. He was also the Deputy Director General of Abarbanel Mental Health Center, the largest acute psychiatric hospital in Israel, from 1999 to 2001. Dr. Molcho holds an MD from Tel Aviv University School of Medicine and an MBA from Tel Aviv University Recanati Business School.